Work

CARDINAL: A Phase 1, Multicenter, Open-Label, Dose-Escalation and Dose-Optimization Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Chronic Myeloid Leukemia

Year: 2024

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)00615-3

Authors: Elias Jabbour, Delphine Réa, Jorge Cortes, Andreas Hochhaus, Timothy Hughes, Dong-Wook Kim, Hagop Kantarjian, Leanne Holes, Emil Kuriakose, Michael Mauro

Institutions: The University of Texas MD Anderson Cancer Center, Hôpital Saint-Louis, Augusta University, Jena University Hospital, Royal Adelaide Hospital, Eulji Medical Center, Eulji University Uijeongbu Eulji Medical Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401878490

FWCI:

Cites:

Cited by:

Related to: 10